iSpecimen to acquire Foldlab AI assets for $4.5 million
iSpecimen entered an Asset Purchase Agreement to acquire Foldlab AI software, models, source code, data rights and related IP and assets. Deal value is $4.5 million, including $2.0 million in cash.
iSpecimen entered into an Asset Purchase Agreement to acquire Foldlab AI software, models, source code, data rights, IP and related assets, including disease-protein discovery and disease-trend AI tools.
The $4.5 million deal includes $2.0 million in cash ($750,000 at closing and two $625,000 miles…